The longevity biotech is accelerating toward the

Biomarker intelligence company launches Terra pl

Deep Science Ventures and Medicines Discovery Ca

Clinic taps growing demand for personalized heal

New $400 million initiative will combine human b

C2N Diagnostics has formed a collaboration with S

Voyager Therapeutics announced FDA clearance of i

Eccogene and AstraZeneca will present multiple cl

Augustine Therapeutics will present a late-breaki

Corsair Pharma completed a first-in-human phase 1

NanoDetection Technology and Oligomerix have exec

HeartSciences launched MyoVista Insights version

Australian regulators clear Scribe Therapeutics

Muse cells show promise across a range of early

TimePie’s 7th longevity forum will bring toget

The company’s gene therapy candidate aims to s

HAYA Therapeutics announced that the first cohort

CellProthera is advancing its CD34+ stem cell the

Kailera Therapeutics, listed on Nasdaq as KLRA an

Mayrlife Medical Health Resort Altaussee launched

Junevity will present new data at the American Ag

Arrowhead Pharmaceuticals reported fiscal second-

Rejuvenate Biomed has completed recruitment in it

Lysoway Therapeutics has received an additional r

Eisai announced the expansion of its Magnolia Mea

From ovarian aging to healthcare access, the fin

New program combines supplements, prescriptions

Jupiter Neurosciences starts enrolling patients

From lab-grown mini livers to engineered bile du

Experimental therapy cut precancerous skin lesio

AstraZeneca’s IMFINZI (durvalumab) in combinati

ŌURA introduced Oura Ring 5, a smart ring that i

Rubedo Life Sciences reported preliminary Phase 1

Aeon Clinic has introduced targeted NAD+ IV thera

Elysium announced the launch of The Elysium Longe

Circulate Health announced that a study published

A new Longevity Show commentary suggests that tr

Patented MT Company’s Volodymyr Naumenko expla

The Healthy Ageing and Longevity Assembly 2026 a

New research suggests sleep complaints in older

resbiotic teams up with Tiny Health to bring res

Scribe Therapeutics presented late-breaking precl

Human Longevity, Inc.

On 27 May 2026, Verge Labs, formerly Verge Genomi

Ribo has submitted a Phase 2 clinical trial appli

Avaí Bio and Austrianova’s Nevada joint ventur

SynuSight Biotech announced a collaborative study

BioCardia reported that Japan’s Pharmaceutical

ABILITY Neurotech wins approval for the first lo

California-based startup bets on AI-designed bio